Iterum Therapeutics plc (ITRM) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $0.03 (-53.84%)
Consensus Target
—
Upside
—
Analysts
1
Rating
Hold(3.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Hold
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
ITRM vs Sector & Market
| Metric | ITRM | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | — | +1708.8% | +16.4% |
| P/E Ratio | -0.03 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9M | $9M | $9M | 1 |
| 2027-12-31 | $41M | $41M | $41M | 1 |
| 2028-12-31 | $49M | $49M | $49M | 1 |
| 2029-12-31 | $76M | $76M | $76M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.31 | $-0.31 | $-0.31 | 1 |
| 2027-12-31 | $-0.41 | $-0.41 | $-0.41 | 1 |
| 2028-12-31 | $-0.19 | $-0.19 | $-0.19 | 1 |
| 2029-12-31 | $0.14 | $0.14 | $0.14 | 1 |
Frequently Asked Questions
What is the analyst consensus for ITRM?
The consensus among 1 analysts covering Iterum Therapeutics plc (ITRM) is Hold with an average price target of N/A.
How many analysts cover ITRM?
1 analysts have issued ratings for Iterum Therapeutics plc in the past 12 months.
Is ITRM a buy or sell right now?
Based on 1 analyst ratings, ITRM has a consensus rating of Hold (3.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for ITRM?
Analysts estimate ITRM will report EPS of $-0.31 for the period ending 2026-12-31, with revenue estimated at $9M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.